Significant Ownership of ARCH Venture Fund X, L.P.

Signature - Title
ARCH Venture Partners X, L.P. - its General Partner
Location
Chicago, IL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ARCH Venture Fund X, L.P..

Notify me when ARCH Venture Fund X, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ARCH Venture Fund X, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MAZE Maze Therapeutics, Inc. Common Stock par value $0.0001 per share 9.4% $36.2M 4.12M ARCH Venture Fund X, L.P. 31 Mar 2025

Schedules 13D/G Reported by ARCH Venture Fund X, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.